Trials for AstraZeneca's coronavirus treatment set to begin in UKChristian Fernsby ▼ | November 21, 2020
The UK will be the first country to begin clinical trials of a new coronavirus antibody treatment developed by drugs giant AstraZeneca PLC aimed at people with a weakened immune system who cannot be vaccinated.
The clinical trial programme will recruit 5,000 participants, which includes 1,000 people from nine sites in the UK.
The aim of the trial is to evaluate the safety and effectiveness of a combination of two long-acting monoclonal antibodies man made proteins that act like natural human antibodies in the immune system. ■